Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma

finance.yahoo.com/news/viatris-gains-china-approval-copd-125910115.html

In This Article:
Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval from China’s National Medical Products Administration/NMPA for Yupelri (revefenacin) inhalation solution for the maintenance treatment of chronic…

This story appeared on finance.yahoo.com, 2025-07-15 12:59:10.
The Entire Business World on a Single Page. Free to Use →